ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 4 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $6,368,000 | +107.4% | 157,975 | +196.1% | 0.00% | +100.0% |
| Q2 2015 | $3,070,000 | -63.6% | 53,347 | -59.7% | 0.00% | -60.0% |
| Q1 2015 | $8,436,000 | +180.5% | 132,505 | +171.9% | 0.01% | +150.0% |
| Q4 2014 | $3,008,000 | +1005.9% | 48,726 | +595.8% | 0.00% | – |
| Q3 2014 | $272,000 | +306.0% | 7,003 | +259.5% | 0.00% | – |
| Q2 2014 | $67,000 | -99.6% | 1,948 | -99.5% | 0.00% | -100.0% |
| Q1 2014 | $16,277,000 | +60.2% | 376,647 | +47.7% | 0.01% | +66.7% |
| Q4 2013 | $10,163,000 | +3265.2% | 255,090 | +3063.3% | 0.01% | – |
| Q3 2013 | $302,000 | +36.0% | 8,064 | -2.5% | 0.00% | – |
| Q2 2013 | $222,000 | – | 8,274 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,417,548 | $255,675,000 | 13.66% |
| HWG Holdings LP | 339,799 | $13,538,000 | 8.73% |
| DOWLING & YAHNKE LLC | 675,798 | $26,924,000 | 3.78% |
| GARRISON BRADFORD & ASSOCIATES INC | 99,300 | $3,956,000 | 3.74% |
| WILLIAM HARRIS INVESTORS INC | 283,834 | $11,308,000 | 3.35% |
| SECTORAL ASSET MANAGEMENT INC | 1,222,401 | $48,700,000 | 2.10% |
| AVALON CAPITAL MANAGEMENT | 49,999 | $1,992,000 | 1.68% |
| PINNACLE ASSOCIATES LTD | 2,016,369 | $80,332,000 | 1.57% |
| PERKINS CAPITAL MANAGEMENT INC | 48,515 | $1,933,000 | 1.30% |
| NCM Capital Advisers, Inc. | 31,100 | $1,239,000 | 1.28% |